title: Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src.
authors.forename: Marco
authors.initials: M
authors.lastname: Perez
authors.forename: Antonio
authors.initials: A
authors.lastname: Lucena-Cacace
authors.forename: Luis Miguel
authors.initials: LM
authors.lastname: Marín-Gómez
authors.forename: Javier
authors.initials: J
authors.lastname: Padillo-Ruiz
authors.forename: Maria Jose
authors.initials: MJ
authors.lastname: Robles-Frias
authors.forename: Carmen
authors.initials: C
authors.lastname: Saez
authors.forename: Rocio
authors.initials: R
authors.lastname: Garcia-Carbonero
authors.forename: Amancio
authors.initials: A
authors.lastname: Carnero